Identifying molecular differences between primary and metastatic colorectal cancers—now possible with the aid of omics technologies—can improve our understanding of the biological mechanisms of cancer progression and facilitate the discovery of novel treatments for late-stage cancer. | The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers